# About NXT LVL Peptides — An Independent GH-Axis Research Desk

> About NXT LVL Peptides: an independent literature digest on three Growth Hormone Axis research peptides. How it is compiled, what it covers, and what it is not — not a seller, not a clinic, not medical advice.

An independent digest on GH-axis research peptides. Not a clinic. Not a source.

## What this site is

NXT LVL Peptides is an independent editorial reference on three compounds studied for the growth hormone / IGF-1 axis: CJC-1295, CJC-1295 / Ipamorelin, and tesamorelin, with tesamorelin as the lead. It exists to state, plainly and with citations, what the published research actually found for each compound — in what population, over what duration, and with what caveats.

The organizing frame is body composition: all three compounds are studied, in one way or another, for their downstream effect on fat and lean mass through GH and IGF-1. They differ sharply in evidence quality. Tesamorelin is FDA-approved, with a Phase 3 trial record, for one narrow HIV-specific indication. CJC-1295 has early pharmacology data but no approval and no body-composition trial. CJC-1295 / Ipamorelin, as a fixed combination, has no trial at all — its case rests on component data and receptor mechanism.

This site holds all three to the same standard: state what was measured, in whom, and stop there.

## How it is compiled

Every factual claim traces to a numbered source on the [references page](/references) — peer-reviewed journal articles, a federal drug-safety monograph, and systematic reviews, with DOIs and PubMed links. Findings are reported in the population and duration they were studied in. A Phase 2 finding is labeled as Phase 2. A finding from 11 or 13 healthy adults is described as coming from 11 or 13 healthy adults, not generalized past that.

Community-reported effects appear only where real data exists, are explicitly labeled anecdotal, and are never attached to a dose. Where a compound has no approved use, or a combination has never been trialed, that gap is stated directly rather than glossed over. Where two compounds share a mechanism or a caution, the pages cross-link so the pattern is visible across the whole desk.

## What this site is not

NXT LVL Peptides is not a pharmacy, clinic, telehealth service, or vendor. It does not sell, source, or broker any compound, and has no affiliate relationship with any supplier, pharmaceutical company, or telehealth provider. It does not diagnose, prescribe, or recommend a dose for any person or use.

Tesamorelin is a prescription medicine available only through a licensed provider, for its approved indication. CJC-1295 and CJC-1295 / Ipamorelin are not approved for human use anywhere and are prohibited in sport under WADA rules at all times. Readers seeking clinical guidance should consult a licensed healthcare provider. Editorial correspondence — citation corrections, newly published trials, regulatory updates — can be directed to the [contact page](/contact); this desk cannot respond to requests for medical advice.

---

A research digest on GH-axis peptides — it reports what the studies show, and stops there. No clinic. No sourcing.